Retatrutide, the triple receptor agonist targeting GLP-1 , GIP, and glucagon receptors simultaneously, requires precise dosing that changes every four weeks as you titrate upward
Before treatment, his CGM showed: frequent glucose spikes after meals a persistently elevated baseline glucose , even between meals and overnight This pattern suggests prolonged glucose exposure and repeated insulin demand throughout the day
Best for nausea, constipation, and nothing sounds good Hydrating foods shine when symptoms stack up
Curr Opin Physiol
Parnham also expressed hesitation about the way Sikiric presented the data, describing him as wielding flashy slides with too much certainty, like a marketing pitch. At the end of 2009, the licensing rights to BPC-157 were returned to Sikiric, along with all of the data that PLIVA had generated